biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Jun 28, 2016 9:52pm

77 Views

Post# 25007024

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Update

C'mon, be honest. Where's your sense of humour? JD's post was pretty funny. You barely have a clue what BTI is doing. How could you possibly know if RH said something new.

Oh ya, I forgot. Nothing new because the price didn't go up today. Half the pharmas left because the price didn't go up today. The rest of them are doing nothing because the price didn't go up today. No one is sold on the "technology" because the price didn't go up today. Nothing happening for the rest of the year because the price didn't go up today.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"